TIS

EQS-News: PSI Strengthens Management in Technology and Development

Retrieved on: 
måndag, juni 17, 2024
SAP, Software as a service, Fraunhofer Society, Supply, Gesellschaft mit beschränkter Haftung, Infrastructure as a service, TIS, Cloud computing, Mannheim Business School, PSI, Management

Berlin, June 12, 2024 - PSI appoints a Chief Technology Officer (CTO) for the first time and fills the position with Erol Bozak (50).

Key Points: 
  • Berlin, June 12, 2024 - PSI appoints a Chief Technology Officer (CTO) for the first time and fills the position with Erol Bozak (50).
  • His area of responsibility includes the central development team and the Research & Development activities.
  • One of his focuses will be the cloud transformation of the PSI portfolio.
  • The PSI Group develops software products for optimizing the flow of energy and materials for utilities and industry.

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

Retrieved on: 
fredag, juni 14, 2024
Congress, News, Hydroxychloroquine, SLE, Male, Tacrolimus, Patient, Immune system, Methotrexate, Cyclophosphamide, Infection, CRS, Safety, Clinical trial, Rituximab, Disease, Leukopenia, Flow cytometry, Glucocorticoid, Prednisone, Cytokine release syndrome, TIS, Immunoglobulin therapy, Belimumab, Potential, Myopathy, EULAR, Symposia, Organic acid, Pharmaceutical industry

“We are encouraged by the initial safety, clinical and translational data from the RESET-Myositis and RESET-SLE trials which we believe provide important early validation regarding the potential of the selected clinical dose of CABA-201 to enable an immune system reset for patients with autoimmune diseases.

Key Points: 
  • “We are encouraged by the initial safety, clinical and translational data from the RESET-Myositis and RESET-SLE trials which we believe provide important early validation regarding the potential of the selected clinical dose of CABA-201 to enable an immune system reset for patients with autoimmune diseases.
  • Cabaletta is advancing four Phase 1/2 RESET trials evaluating CABA-201 within a total of ten cohorts with six patients in each cohort.
  • ET to review the initial clinical data presented at the satellite symposium at the EULAR 2024 Congress and provide an update on the RESET clinical development program.
  • A webcast of the live call can be accessed on the News and Events section of the Company’s website at www.cabalettabio.com .

NewLake Capital Partners Reports First Quarter 2024 Financial Results

Retrieved on: 
torsdag, maj 9, 2024
Common, Tenant, Conference, TIS, Growth, FFO, Cannabis, Comparison, TI, Holding company

NEW CANAAN, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OCTQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the first quarter ended March 31, 2024.

Key Points: 
  • First Quarter 2024 Revenue Totaled $12.6 Million, an increase of 10.4% Year-Over-Year
    First Quarter 2024 Net Income Attributable to Common Stockholders Totaled $6.9 Million, Funds from Operations Totaled $10.6 Million, and Adjusted Funds from Operations Totaled $11.0 Million
    Conference Call and Webcast Scheduled for May 9, 2024, at 11 a.m. Eastern Time
    NEW CANAAN, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OCTQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the first quarter ended March 31, 2024.
  • Anthony Coniglio, President and Chief Executive Officer, said, “We are pleased with the performance of our portfolio and financial results during the first quarter of 2024.
  • As a result, presented below reflects only the first quarter financial results.
  • Comparison to the first quarter ended March 31, 2023:
    Quarterly year-over-year financial results were impacted by the non-payment of contractual rent from one tenant in 2023.

Molex Combines High-Speed Data, Signal and Power in MX-DaSH Data-Signal Hybrid Connector Portfolio to Optimize Next-Gen Automotive Architectures

Retrieved on: 
tisdag, maj 7, 2024
Peugeot, IEC, USCAR, Freedom, Original equipment manufacturer, Electronics, TIS, Lidar, Molex, GPS, Printed circuit board

These include autonomous driving modules, camera systems, GPS and infotainment devices, LiDAR, high-resolution displays, sensor-device connectivity and more.

Key Points: 
  • These include autonomous driving modules, camera systems, GPS and infotainment devices, LiDAR, high-resolution displays, sensor-device connectivity and more.
  • MX-DaSH connectors are available with sealed and unsealed options to optimize next-gen automotive architectures with assorted environmental and design requirements.
  • With the new MX-DaSH family, automotive OEMs and their suppliers can better meet escalating demands for more compact, hybrid connectivity to support a multitude of automotive applications.
  • For instance, the 31+1-Way connector system combines 31 power and ground circuits, as well as a high-speed data connection, to decrease packaging requirements by up to 30%.

Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting

Retrieved on: 
onsdag, april 24, 2024
Biotechnology, General Health, Health, Pharmaceutical, Oncology, Information, Acalabrutinib, Colorectal cancer, BCL2, Follicular lymphoma, Patient, Comparison, TIS, HPK1, Tislelizumab, Lymphoid leukemia, Pharmaceutical industry

Comparison of zanubrutinib (zanu) and acalabrutinib (acala) in B-cell malignancies: an adverse event (AE)-based analysis

Key Points: 
  • Comparison of zanubrutinib (zanu) and acalabrutinib (acala) in B-cell malignancies: an adverse event (AE)-based analysis
    Real-world evaluation of treatment pattern, time to next treatment (TTNT), healthcare resource utilization (HCRU), and cost of care in follicular lymphoma (FL)
    BGB-11417-203, an ongoing, phase 2 study of sonrotoclax (BGB-11417), a next-generation BCL2 inhibitor, in patients with Waldenström macroglobulinemia
    Session Type and Title: Poster Session – Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
    Preoperative (neoadjuvant) therapy with tislelizumab for locally advanced colorectal cancer with high microsatellite instability or deficient mismatch repair: an open-label, single-arm, multicenter phase II study
    Tislelizumab First-Line (1L) Gastric/Gastroesophageal Junction Cancer (G/GEJ) Treatment Efficacy on PRO-Based Symptom Endpoints Adjusting for Informative Missing Data Bias: Results from RATIONALE 305
    A first‑in‑human phase 1a dose‑escalation study of BGB‑15025 (HPK1 inhibitor) as monotherapy and in combination with tislelizumab (TIS; anti‑PD‑1 antibody) in patients (pts) with advanced solid tumors
    Long-term pooled safety analysis of tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers.

Tetrate Launches Open Source 'Authservice' in Collaboration with the US Air Force Platform One Team to Simplify Cloud-Native Authentication

Retrieved on: 
onsdag, april 17, 2024
Air force, HIPAA, GDPR, SSO, Partnership, Policy, Zero trust security model, FedRAMP, Documentation, RBAC, OpenID, USAF, TIS, OIDC, NIST, API, Organization, SAN, Mobile phone

SAN FRANCISCO, April 17, 2024 /PRNewswire-PRWeb/ -- Tetrate, the company bringing Istio and Envoy to the enterprise, in partnership with the United States Air Force (USAF) Platform One team, has launched Authservice, an open source project that sets a new standard in cloud-native authentication and compliance. With OpenID Connect (OIDC) integration and seamless Kubernetes support, Authservice allows developers to protect APIs and web apps without application code.

Key Points: 
  • Authservice offers scalability and operational simplicity in cloud environments as a drop-in replacement for the existing Istio authservice.
  • Authservice uses Istio mesh sidecars and Kubernetes secrets to provide dynamic, automated support for authentication.
  • "Authservice is a groundbreaking advancement in cloud-native security, and we're delighted to make it available as an open source project," said Branden Wood, federal director at Tetrate.
  • Platform One is a cloud-based software development platform used by the USAF to build secure and compliant software applications.

TIS Has Signed Binding Agreement with Marlin Equity Partners to Secure a Majority Growth Investment

Retrieved on: 
tisdag, mars 26, 2024
Growth, CFO, Partnership, Guggenheim Partners, TIS, Treasury, Senior management, B2B, Cryptocurrency

Marlin Equity Partners has signed a binding agreement to acquire a majority stake in Treasury Intelligence Solutions.

Key Points: 
  • Marlin Equity Partners has signed a binding agreement to acquire a majority stake in Treasury Intelligence Solutions.
  • Co-founder Joerg Wiemer, Aquiline Capital Partners LP, and the Management Team retain significant minority positions in the company.
  • BERLIN, Germany, Mar 26, 2024 - (ACN Newswire) - Today, Treasury Intelligence Solutions ("TIS"), a global leader in cloud-native cash management, liquidity and payment solutions, announced that it has signed a binding agreement to secure majority growth investment from Marlin Equity Partners ("Marlin").
  • The investment positions TIS to execute on organic and inorganic strategic initiatives to further serve the Office of the CFO.

ZoomInfo and TrustRadius Partner To End Revenue Anxiety

Retrieved on: 
tisdag, april 9, 2024
EST, ROI, Organization, Noise, Acceleration, Partnership, Research, Churn, TIS, Marketing, Sales

AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- Today, TrustRadius and ZoomInfo announce their new integration that sales and marketing teams have long awaited—a powerful collaboration that combines ZoomInfo's contact-level intelligence with TrustRadius downstream intent data. This integration, facilitated through the ZoomInfo Sales platform, promises to transform how businesses identify, target, and engage with in-market buyers.

Key Points: 
  • AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- Today, TrustRadius and ZoomInfo announce their new integration that sales and marketing teams have long awaited—a powerful collaboration that combines ZoomInfo's contact-level intelligence with TrustRadius downstream intent data.
  • For more information on leveraging the power of TrustRadius and ZoomInfo Sales, join our webinar on April 30, 12 pm EST.
  • The partnership between TrustRadius and ZoomInfo marks a significant milestone in the industry, enabling organizations to kiss revenue anxiety goodbye.
  • "With ZoomInfo and TrustRadius making data-driven selling so accessible, there's no excuse for go-to-market teams to sell any other way," ZoomInfo Chief Revenue Officer James Roth said.

Tomahawk Information Solutions Slated To Exhibit at WBENC's AMPLIFY Conference, Empowering Women Entrepreneurs to Connect and Collaborate

Retrieved on: 
måndag, mars 18, 2024
Convention, Conference, Government, Growth, Entrepreneurship, Environment, SAN, History, Female, Women, Woman, Digital transformation, Women's History Month, TIS, Empowerment, CO, Booth, Management

WBENC Amplify in Denver, CO March 18-22 will be the world's largest gathering of female owned companies in history.

Key Points: 
  • WBENC Amplify in Denver, CO March 18-22 will be the world's largest gathering of female owned companies in history.
  • The conference, expected to draw over 4,500 women CEOs and business owners, is the largest gathering of its kind, aimed at fostering collaboration, mentorship, and networking opportunities among women entrepreneurs.
  • TIS will be showcasing their innovative solutions at Booth #2431, connecting with Fortune 500 companies, government agencies, and fellow women-owned businesses.
  • For more information about Tomahawk Information Solutions and their participation in the WBENC AMPLIFY Conference, visit their website at [ www.tom-is.com ]( www.tom-is.com ).

Keysight and ETS-Lindgren Deliver First Narrowband Non-Terrestrial Networks Over-The-Air Test Solution

Retrieved on: 
onsdag, mars 6, 2024
Data Management, Satellite, Technology, Software, Networks, Internet, Hardware, LTE, Gain (antenna), UXM, 3GPP, TIS, TRP, CTIA, NTN, OTA, Partnership

Keysight Technologies, Inc. (NYSE: KEYS) and ETS-Lindgren announce an industry-first over-the-air (OTA) test solution for devices supporting the narrowband non-terrestrial networks (NB-NTN) technology.

Key Points: 
  • Keysight Technologies, Inc. (NYSE: KEYS) and ETS-Lindgren announce an industry-first over-the-air (OTA) test solution for devices supporting the narrowband non-terrestrial networks (NB-NTN) technology.
  • Working in close partnership, Keysight and ETS-Lindgren developed a joint OTA test solution for measuring and validating the transmitter / receiver performance of devices supporting NB-NTN.
  • The combined solution comprises Keysight’s UXM E7515B NTN software and ETS-Lindgren’s OTA test chambers and EMQuest Antenna Measurement Software.
  • The cooperative approach with the Keysight UXM 5G Emulation Solution team helped accelerate the development of this important OTA test and allowed quick integration within EMQuest.”
    Chih Kai Wu, Wireless Solution Director, Keysight Wireless Test Group, said: “Keysight is delighted to partner with ETS-Lindgren to deliver the industry’s first NB-NTN OTA test solution.